Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Lung Lai

Showing results (11-20 of 288) with videos related to

Pageof 29
Sort By:
Hepatology (Baltimore, Md.)|July 19, 2012
Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapyChing-Lung Lai, Man-Fung Yuen
Intervirology|September 17, 2005
Response to combined interferon and ribavirin is better in patients infected with hepatitis C virus genotype 6 than genotype 1 in Hong KongMan-Fung Yuen, Ching-Lung Lai
Journal of Clinical Gastroenterology|December 17, 2004
Treatment for hepatitis B: a public health perspectiveMan-Fung Yuen, Ching-Lung Lai
Expert Review of Gastroenterology & Hepatology|December 17, 2008
Hepatitis B virus genotypes: natural history and implications for treatmentMan-Fung Yuen, Ching-Lung Lai
Journal of Gastroenterology and Hepatology|January 22, 2003
Memoir on hepatitis and liver disease history in Hong KongChing-Lung Lai, Shiu-Kum Lam
The New England Journal of Medicine|July 21, 2006
Hepatitis B virus with primary resistance to adefovirTing-Tsung Chang, Ching-Lung Lai
Expert Opinion on Pharmacotherapy|October 25, 2006
Recommendations and potential future options in the treatment of hepatitis BMan-Fung Yuen, Ching-Lung Lai
Expert Opinion on Pharmacotherapy|October 27, 2004
Adefovir dipivoxil in chronic hepatitis B infectionMan-Fung Yuen, Ching-Lung Lai
Best Practice & Research. Clinical Gastroenterology|March 11, 2005
Serological markers of liver cancerMan-Fung Yuen, Ching-Lung Lai
The American Journal of Gastroenterology|February 3, 2007
Combination therapy for chronic hepatitis B: simultaneous or sequential?Man-Fung Yuen, Ching-Lung Lai
Pageof 29

Showing results (11-20 of 288) with videos related to

Sort By:
Pageof 29
Hepatology (Baltimore, Md.)|July 19, 2012
Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapyChing-Lung Lai, Man-Fung Yuen
Intervirology|September 17, 2005
Response to combined interferon and ribavirin is better in patients infected with hepatitis C virus genotype 6 than genotype 1 in Hong KongMan-Fung Yuen, Ching-Lung Lai
Journal of Clinical Gastroenterology|December 17, 2004
Treatment for hepatitis B: a public health perspectiveMan-Fung Yuen, Ching-Lung Lai
Expert Review of Gastroenterology & Hepatology|December 17, 2008
Hepatitis B virus genotypes: natural history and implications for treatmentMan-Fung Yuen, Ching-Lung Lai
Journal of Gastroenterology and Hepatology|January 22, 2003
Memoir on hepatitis and liver disease history in Hong KongChing-Lung Lai, Shiu-Kum Lam
The New England Journal of Medicine|July 21, 2006
Hepatitis B virus with primary resistance to adefovirTing-Tsung Chang, Ching-Lung Lai
Expert Opinion on Pharmacotherapy|October 25, 2006
Recommendations and potential future options in the treatment of hepatitis BMan-Fung Yuen, Ching-Lung Lai
Expert Opinion on Pharmacotherapy|October 27, 2004
Adefovir dipivoxil in chronic hepatitis B infectionMan-Fung Yuen, Ching-Lung Lai
Best Practice & Research. Clinical Gastroenterology|March 11, 2005
Serological markers of liver cancerMan-Fung Yuen, Ching-Lung Lai
The American Journal of Gastroenterology|February 3, 2007
Combination therapy for chronic hepatitis B: simultaneous or sequential?Man-Fung Yuen, Ching-Lung Lai
Pageof 29